PRKAR1A Gene Pigmented Nodular Adrenocortical Disease Type 1 Primary Genetic Test
Are you concerned about Pigmented Nodular Adrenocortical Disease Type 1 (PNA1)? DNA Labs UAE offers a comprehensive and advanced genetic test to analyze the PRKAR1A gene associated with PNA1.
Test Components and Price
- Test Name: PRKAR1A Gene Pigmented Nodular Adrenocortical Disease Type 1 Primary Genetic Test
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Hepatology Nephrology Endocrinology Disorders
- Doctor: General Physician
- Test Department: Genetics
Pre Test Information
Prior to undergoing the PRKAR1A Gene Pigmented Nodular Adrenocortical Disease Type 1 Primary Genetic Test, it is important to provide the clinical history of the patient. A genetic counseling session will be conducted to draw a pedigree chart of family members affected by PNA1 and the PRKAR1A gene.
Test Details
The PRKAR1A gene is associated with a rare genetic disorder called Pigmented Nodular Adrenocortical Disease Type 1 (PNA1). PNA1 is characterized by the development of multiple small nodules in the adrenal glands, which are responsible for hormone production.
The primary NGS genetic test utilizes next-generation sequencing (NGS) technology to analyze the DNA sequence of the PRKAR1A gene. NGS allows for the simultaneous analysis of multiple genes or even the entire genome, providing a comprehensive view of genetic variations.
By analyzing the PRKAR1A gene using NGS, healthcare professionals can identify any variations or mutations in the gene that may be associated with PNA1. This genetic testing approach helps confirm a diagnosis of PNA1 and can also be used for genetic counseling and family planning purposes.
It is important to note that genetic testing for PNA1 is typically recommended for individuals who have symptoms suggestive of the condition or a family history of PNA1. Early detection through genetic testing can lead to better management and treatment options for affected individuals.
Test Name | PRKAR1A Gene Pigmented nodular adrenocortical disease type 1 primary Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Hepatology Nephrology Endocrinology Disorders |
Doctor | General Physician |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for PRKAR1A Gene Pigmented nodular adrenocortical disease type 1, primary NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with PRKAR1A Gene Pigmented nodular adrenocortical disease type 1, primary NGS Genetic DNA Test gene PRKAR1A |
Test Details |
The PRKAR1A gene is associated with a condition called pigmented nodular adrenocortical disease type 1 (PNA1). PNA1 is a rare genetic disorder characterized by the development of multiple small nodules in the adrenal glands, which are responsible for producing hormones such as cortisol and aldosterone. The primary NGS genetic test refers to the use of next-generation sequencing (NGS) technology to analyze the DNA sequence of the PRKAR1A gene. NGS allows for the simultaneous analysis of multiple genes or even the entire genome, providing a comprehensive view of genetic variations. By analyzing the PRKAR1A gene using NGS, healthcare professionals can identify any variations or mutations in the gene that may be associated with PNA1. This genetic testing approach helps in confirming a diagnosis of PNA1 and can also be used for genetic counseling and family planning purposes. It is important to note that genetic testing for PNA1 is typically recommended for individuals who have symptoms suggestive of the condition or a family history of PNA1. Genetic testing can help in early detection, which may lead to better management and treatment options for affected individuals. |